Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| fusion
|  
|  
|  
|
with TNFRSF6 in several cancer cell lines (prostate, breast, cervical bladder) | tumoral
|  
|  
| --low
|  
|
by hypermethylation, methylation being both age-dependent and tumor differentiation-dependent, in late- stage prostate carcinoma | tumoral
|  
| amplification
|  
|  
|
in proliferative breast disease and breast cancer | constitutional
|  
|  
|  
| loss of function
|
inactivation through methylation of TUSC3 and ESR1 associated with ulcerative colitis, but not with colrectal carcinoma | tumoral
|  
| amplification
|  
|  
|
may be an early event in endometrial carcinoma development | |
Variant & Polymorphism
SNP
, repeat
, other
| (TA)n repeat variant (short alleles) |
|
haplotype px associated with reduced hip bone mass density and risk of femoral neck bone loss in postmenopausal women |
|
G allele containing variants of ESR1 XbaI may decrease the risk of hypospadias, whereas the ESR1 C-A haplotype may increase its risk |
|
homozygosity for the specific ESR1 haplotype in the development of cryptorchidism |
|
SNP increasing the risk of type 2 diabetes patients with nephropathy |
|
variant associated with idiopathic male infertility |
|
SNP rs2046210 at 6q25.1, located upstream of ESR1, showed strong and consistent association with breast cancer across all three stages (Zheng 2009) |
|
|